Colleen Kelly: Bridging the Access Gap in Gene Therapy for Sickle Cell Disease
Colleen Kelly, Attending Physician and Pediatric Hematologist/Oncologist at Dana-Farber Cancer Institute and Boston Children’s Hospital, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Pediatric Blood and Cancer, adding:
“Our new paper is out in Pediatric Blood and Cancer.
Gene therapy can be a transformative treatment for sickle cell disease. But its resource- and time-intensive nature may limit who can actually access it.
In our study, 60% of families with a child with sickle cell disease faced material hardship — food, housing, utility, or transportation insecurity — in the last year.
Only 40% of parents felt they could access gene therapy with their current resources. And families facing material hardship were far less likely to report being able to access this treatment, with 95% lower odds after adjustment.
A transformative therapy is only effective if families can reach it. As these life-changing but resource-intensive therapies expand, access must be part of the design.”
Title: Out of Reach: Understanding Resource Barriers to Gene Therapy for Pediatric Patients With Sickle Cell Disease
Authors: Colleen A. Kelly, Morgan A. Paul, McKenzie Griffin, Sunyu Kang, Rahela Aziz-Bose, Leanne Duhaney, Callie Fry, Puja J. Umaretiya, Kristine Karvonen, Erica Esrick, Sharl Azar, Natasha M. Archer, Kira Bona

Stay updated on all scientific advances with Hemostasis Today.
-
Jul 27, 2026, 07:59James P. Crowley: A New Era in Cardiovascular Risk Prevention
-
Jul 27, 2026, 07:42Shayan Mohammadmoradi: Leading Membership Growth and Scientific Engagement in ATVB
-
Jul 27, 2026, 07:29Maliheh Davari: Exploring CRISPR Activation for Hemophilia at ISTH 2026
-
Jul 27, 2026, 06:45Maha Othman: The Value of Trusted Scientific Reporting at ISTH 2026
-
Jul 27, 2026, 04:50A Significant Step Forward for People with Bleeding Disorders in the Dominican Republic – WFH
-
Jul 27, 2026, 04:11Mohamed F Doheim: Clarifying the Role of Late IV Thrombolysis in the Era of Endovascular Therapy
-
Jul 27, 2026, 03:50Françoise Dignat-George: The Rising Impact of Extracellular Vesicles Spotlighted at ISTH 2026
-
Jul 27, 2026, 03:42Koson Tony Sriamporn: A Milestone for Inclusive Blood Donor Eligibility
-
Jul 27, 2026, 03:34Wolfgang Miesbach: A Standout Talk by Jeffrey Weitz at ISTH 2026